Therefore, even though diabetes, depression, and DD regulate secretion of DA, 5-HT, and NA, CX3CR1 blocker treatment modulates the secretion of the three monoamine neurotransmitters in DD rats. Here, CX3CR1 is linked to depressive disorder.